Aveanna Healthcare Hldgs Analyst Ratings
Aveanna Healthcare Hldgs Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2023 | 4.94% | Truist Securities | $1.4 → $1.7 | Maintains | Hold |
| 05/15/2023 | 23.46% | RBC Capital | → $2 | Reiterates | Sector Perform → Sector Perform |
| 05/12/2023 | -38.27% | Credit Suisse | → $1 | Reiterates | Underperform → Underperform |
| 05/12/2023 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 03/20/2023 | 23.46% | RBC Capital | $3 → $2 | Maintains | Sector Perform |
| 03/20/2023 | 85.19% | Raymond James | $4 → $3 | Maintains | Strong Buy |
| 03/17/2023 | -13.58% | Truist Securities | $1 → $1.4 | Maintains | Hold |
| 01/27/2023 | -38.27% | Credit Suisse | $2 → $1 | Downgrades | Neutral → Underperform |
| 11/21/2022 | 85.19% | RBC Capital | $7 → $3 | Downgrades | Outperform → Sector Perform |
| 11/17/2022 | 23.46% | Credit Suisse | $5.5 → $2 | Downgrades | Outperform → Neutral |
| 11/16/2022 | 146.91% | Raymond James | $6 → $4 | Maintains | Strong Buy |
| 11/11/2022 | -7.41% | Stephens & Co. | $2.25 → $1.5 | Maintains | Equal-Weight |
| 08/19/2022 | 208.64% | Barclays | $7 → $5 | Maintains | Overweight |
| 08/15/2022 | 270.37% | Raymond James | $8 → $6 | Maintains | Strong Buy |
| 07/22/2022 | 54.32% | Jefferies | $9 → $2.5 | Downgrades | Buy → Hold |
| 07/05/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 06/21/2022 | 116.05% | Stephens & Co. | $5.5 → $3.5 | Downgrades | Overweight → Equal-Weight |
| 03/31/2022 | 393.83% | Raymond James | $12 → $8 | Maintains | Strong Buy |
| 03/31/2022 | 455.56% | RBC Capital | $16 → $9 | Maintains | Outperform |
| 03/30/2022 | 208.64% | Truist Securities | $10 → $5 | Maintains | Buy |
| 03/30/2022 | 270.37% | Deutsche Bank | $12.5 → $6 | Maintains | Buy |
| 03/30/2022 | 332.1% | Stephens & Co. | $11.5 → $7 | Maintains | Overweight |
| 03/30/2022 | 332.1% | Barclays | $16 → $7 | Maintains | Overweight |
| 03/30/2022 | 486.42% | Credit Suisse | $12 → $9.5 | Maintains | Outperform |
| 03/29/2022 | 239.51% | B of A Securities | $10 → $5.5 | Downgrades | Buy → Neutral |
| 11/23/2021 | 640.74% | Raymond James | $15 → $12 | Maintains | Strong Buy |
| 05/24/2021 | 764.2% | JP Morgan | → $14 | Initiates Coverage On | → Neutral |
| 05/24/2021 | 825.93% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 05/24/2021 | 825.93% | Raymond James | → $15 | Initiates Coverage On | → Strong Buy |
| 05/24/2021 | 733.33% | Deutsche Bank | → $13.5 | Initiates Coverage On | → Buy |
| 05/24/2021 | 887.65% | Credit Suisse | → $16 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 949.38% | BMO Capital | → $17 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 887.65% | RBC Capital | → $16 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 1134.57% | Barclays | → $20 | Initiates Coverage On | → Overweight |
| 05/24/2021 | 825.93% | Truist Securities | → $15 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 07/13/2023 | 4.94% | Truist证券 | $1.4→$1.7 | 维护 | 保持 |
| 2023年05月15日 | 23.46% | 加拿大皇家银行资本 | →$2 | 重申 | 扇区表现→扇区表现 |
| 2023年05月12日 | -38.27% | 瑞士信贷 | →$1 | 重申 | 表现不佳→表现不佳 |
| 2023年05月12日 | - | 雷蒙德·詹姆斯 | 评级下调 | 强劲的购买→市场表现 | |
| 03/20/2023 | 23.46% | 加拿大皇家银行资本 | $3→$2 | 维护 | 行业表现 |
| 03/20/2023 | 85.19% | 雷蒙德·詹姆斯 | $4→$3 | 维护 | 强势购买 |
| 03/17/2023 | -13.58% | Truist证券 | $1→$1.4 | 维护 | 保持 |
| 2023年1月27日 | -38.27% | 瑞士信贷 | $2→$1 | 评级下调 | 中性→表现不佳 |
| 2022年11月21日 | 85.19% | 加拿大皇家银行资本 | $7→$3 | 评级下调 | 跑赢→板块表现 |
| 2022年11月17日 | 23.46% | 瑞士信贷 | $5.5→$2 | 评级下调 | 跑赢→中性 |
| 2022年11月16日 | 146.91% | 雷蒙德·詹姆斯 | $6→$4 | 维护 | 强势购买 |
| 2022年11月11日 | -7.41% | 斯蒂芬斯公司 | $2.25→$1.5 | 维护 | 等重 |
| 2022年08月19日 | 208.64% | 巴克莱 | $7→$5 | 维护 | 超重 |
| 2022年08月15日 | 270.37% | 雷蒙德·詹姆斯 | $8→$6 | 维护 | 强势购买 |
| 07/22/2022 | 54.32% | 杰富瑞 | $9→$2.5 | 评级下调 | 购买→Hold |
| 07/05/2022 | - | Truist证券 | 评级下调 | 购买→Hold | |
| 2022年06月21日 | 116.05% | 斯蒂芬斯公司 | $5.5→$3.5 | 评级下调 | 超重→等重 |
| 03/31/2022 | 393.83% | 雷蒙德·詹姆斯 | $12→$8 | 维护 | 强势购买 |
| 03/31/2022 | 455.56% | 加拿大皇家银行资本 | $16→$9 | 维护 | 跑赢大盘 |
| 03/30/2022 | 208.64% | Truist证券 | $10→$5 | 维护 | 买 |
| 03/30/2022 | 270.37% | 德意志银行 | $12.5→$6 | 维护 | 买 |
| 03/30/2022 | 332.1% | 斯蒂芬斯公司 | $11.5→$7 | 维护 | 超重 |
| 03/30/2022 | 332.1% | 巴克莱 | $16→$7 | 维护 | 超重 |
| 03/30/2022 | 486.42% | 瑞士信贷 | $12→$9.5 | 维护 | 跑赢大盘 |
| 03/29/2022 | 239.51% | B of A证券 | $10→$5.5 | 评级下调 | 购买→中性 |
| 2021年11月23日 | 640.74% | 雷蒙德·詹姆斯 | $15→$12 | 维护 | 强势购买 |
| 2021/05/24 | 764.2% | 摩根大通 | →$14 | 开始承保 | →中性 |
| 2021/05/24 | 825.93% | 杰富瑞 | →$15 | 开始承保 | →购买 |
| 2021/05/24 | 825.93% | 雷蒙德·詹姆斯 | →$15 | 开始承保 | →强势购买 |
| 2021/05/24 | 733.33% | 德意志银行 | →$13.5 | 开始承保 | →购买 |
| 2021/05/24 | 887.65% | 瑞士信贷 | →$16 | 开始承保 | →跑赢大盘 |
| 2021/05/24 | 949.38% | 蒙特利尔银行资本 | →$17 | 开始承保 | →跑赢大盘 |
| 2021/05/24 | 887.65% | 加拿大皇家银行资本 | →$16 | 开始承保 | →跑赢大盘 |
| 2021/05/24 | 1134.57% | 巴克莱 | →$20 | 开始承保 | →超重 |
| 2021/05/24 | 825.93% | Truist证券 | →$15 | 开始承保 | →购买 |
What is the target price for Aveanna Healthcare Hldgs (AVAH)?
Aveanna Healthcare Hldgs(Avah)的目标价格是多少？
The latest price target for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was reported by Truist Securities on July 13, 2023. The analyst firm set a price target for $1.70 expecting AVAH to rise to within 12 months (a possible 4.94% upside). 15 analyst firms have reported ratings in the last year.
TRUIST证券于2023年7月13日报道了Aveanna Healthcare Hldgs(纳斯达克：AVA)的最新目标价。这家分析公司将目标价定为1.70美元，预计Avah将在12个月内上涨(可能上涨4.94%)。过去一年，有15家分析公司公布了评级。
What is the most recent analyst rating for Aveanna Healthcare Hldgs (AVAH)?
Aveanna Healthcare Hldgs(Avah)的最新分析师评级是多少？
The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was provided by Truist Securities, and Aveanna Healthcare Hldgs maintained their hold rating.
Aveanna Healthcare Hldgs(纳斯达克代码：AVA)的最新分析师评级由Truist Securities提供，Aveanna Healthcare Hldgs维持持有评级。
When is the next analyst rating going to be posted or updated for Aveanna Healthcare Hldgs (AVAH)?
Aveanna Healthcare Hldgs(Avah)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Aveanna Healthcare Hldgs的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Aveanna Healthcare Hldgs的上一次评级是在2023年7月13日提交的，所以你应该预计下一次评级将在2024年7月13日左右的某个时候提供。
Is the Analyst Rating Aveanna Healthcare Hldgs (AVAH) correct?
分析师对Aveanna Healthcare Hldgs(Avah)的评级正确吗？
While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a maintained with a price target of $1.40 to $1.70. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $1.62, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Aveanna Healthcare Hldgs(Avah)评级维持不变，目标价在1.40美元至1.70美元之间。Aveanna Healthcare Hldgs(Avah)目前的股价为1.62美元，在分析师的预测范围内。